AsianScientist reports that inaccurate allergy labels, particularly for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), can limit treatment options for patients with suspected drug allergies in Hong Kong, leading to potentially poorer outcomes for conditions like stroke. A study by the University of Hong Kong found that stroke patients with NSAID allergy labels were more likely to face mortality and adverse cardiovascular events, with many patients incorrectly labelled as allergic to NSAIDs. The researchers recommend expanded drug allergy testing and innovative strategies to improve accurate labelling and ensure appropriate treatment for patients at risk for cardiovascular diseases.
Full Article
Puma’s new boss takes helm trailing Adidas and a recovering Nike
Puma's leadership has aimed to elevate the brand's image for over two years, focusing on making its sneakers and apparel more aspirational. However, new CEO Arthur Hoeld has indicated that the brand is now perceived as cheap, suggesting a disconnect between the company's goals and public perception. Want More Context? 🔎
Read more